News | July 15, 2020

Together EastCoast Bio, Lee Biosolutions and Medix Biochemica offer a wide range of critical reagents for COVID-19 assay development. Products from each portfolio include:

EastCoast Bio:

• Anti-SARS-CoV-2 Nucleocapsid monoclonal antibodies – NEW
• Anti-SARS-CoV-2 Spike 1 protein monoclonal antibodies – NEW
• Recombinant SARS-CoV-2 Spike 1 and Nucleocapsid antigens

Lee Biosolutions:

• COVID-19 cross-reactivity serum/plasma panel – NEW
• COVID-19 confirmed positive & negative serum/plasma samples
  – NEW SAMPLES
• COVID-19 confirmed positive & negative nasopharyngeal swabs
• Nasal fluid and sputum samples collected prior to November 2019

Medix Biochemica:

• Recombinant SARS-CoV-2 Nucleocapsid, Spike 1, Spike RBD antigens
• Anti-IgG, IgM, and IgA monoclonal antibodies for your serological assays

Please do not hesitate to contact us for more information.